Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Silence Therapeutics (SLN) Revenue: 2020-2025

Historic Revenue for Silence Therapeutics (SLN) over the last 6 years, with Sep 2025 value amounting to $159,000.

  • Silence Therapeutics' Revenue fell 89.39% to $159,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $25.8 million, marking a year-over-year increase of 37.57%. This contributed to the annual value of $43.3 million for FY2024, which is 36.71% up from last year.
  • Per Silence Therapeutics' latest filing, its Revenue stood at $159,000 for Q3 2025, which was down 29.02% from $224,000 recorded in Q2 2025.
  • Silence Therapeutics' Revenue's 5-year high stood at $25.3 million during Q4 2024, with a 5-year trough of $142,000 in Q1 2025.
  • Moreover, its 3-year median value for Revenue was $2.6 million (2023), whereas its average is $6.8 million.
  • Per our database at Business Quant, Silence Therapeutics' Revenue surged by 871.33% in 2024 and then tumbled by 99.10% in 2025.
  • Silence Therapeutics' Revenue (MRQ) stood at $4.6 million in 2021, then rose by 21.44% to $5.6 million in 2022, then tumbled by 53.39% to $2.6 million in 2023, then soared by 871.33% to $25.3 million in 2024, then crashed by 99.37% to $159,000 in 2025.
  • Its Revenue was $159,000 in Q3 2025, compared to $224,000 in Q2 2025 and $142,000 in Q1 2025.